Publication | Closed Access

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

HypertensionHeart FailureChronic Heart FailureCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyAngiotensin-converting-enzyme InhibitorsPharmacotherapyPharmacologyCardiologyCharm-alternative TrialDiastolic Function